Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
EV/Core EBITDA

    Back to All Ratios
VAISHALI PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 46.0243.5414.3510.2811.55

What is the latest EV/Core EBITDA ratio of VAISHALI PHARMA ?

The latest EV/Core EBITDA ratio of VAISHALI PHARMA is 46.02 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202546.02
Mar202443.54
Mar202314.35
Mar202210.28
Mar202111.55

How is EV/Core EBITDA of VAISHALI PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 46.02
5.70
Mar2024 43.54
203.41
Mar2023 14.35
39.59
Mar2022 10.28
-11.00
Mar2021 11.55 -

Other Financial Ratios of VAISHALI PHARMA


Compare EV/Core EBITDA ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹100.9 Cr -8.5% 52.3% -44.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,859.0 Cr 5.2% 3.8% -1.8% Stock Analytics
DIVIS LABORATORIES ₹176,618.0 Cr 2.2% 11.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,718.0 Cr 0.8% 0.7% 25.7% Stock Analytics
CIPLA ₹107,722.0 Cr 1.3% 9.1% -15.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,081.0 Cr -3.5% 2.7% 10.3% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-8.5%

52.3%

-44.6%

SENSEX

0.8%

5%

-2.5%


You may also like the below Video Courses